- Home
- ECVT vs KALV Comparison
ECVT vs KALV Comparison
Compare ECVT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECVT
- KALV
- Stock Information
- Founded
- ECVT 1935
- KALV N/A
- Country
- ECVT United States
- KALV United States
- Employees
- ECVT N/A
- KALV N/A
- Industry
- ECVT Major Chemicals
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- ECVT Industrials
- KALV Health Care
- Exchange
- ECVT Nasdaq
- KALV Nasdaq
- Market Cap
- ECVT 985.1M
- KALV 796.4M
- IPO Year
- ECVT 2017
- KALV N/A
- Fundamental
- Price
- ECVT $8.32
- KALV $10.97
- Analyst Decision
- ECVT Buy
- KALV Strong Buy
- Analyst Count
- ECVT 3
- KALV 8
- Target Price
- ECVT $12.17
- KALV $26.43
- AVG Volume (30 Days)
- ECVT 2.0M
- KALV 1.5M
- Earning Date
- ECVT 10-30-2025
- KALV 09-11-2025
- Dividend Yield
- ECVT N/A
- KALV N/A
- EPS Growth
- ECVT N/A
- KALV N/A
- EPS
- ECVT N/A
- KALV N/A
- Revenue
- ECVT $723,462,000.00
- KALV $1,426,000.00
- Revenue This Year
- ECVT $14.65
- KALV N/A
- Revenue Next Year
- ECVT $0.39
- KALV $213.43
- P/E Ratio
- ECVT N/A
- KALV N/A
- Revenue Growth
- ECVT 4.93
- KALV N/A
- 52 Week Low
- ECVT $5.24
- KALV $7.30
- 52 Week High
- ECVT $9.69
- KALV $17.28
- Technical
- Relative Strength Index (RSI)
- ECVT 37.52
- KALV 32.68
- Support Level
- ECVT $8.43
- KALV $11.93
- Resistance Level
- ECVT $8.92
- KALV $12.04
- Average True Range (ATR)
- ECVT 0.25
- KALV 0.56
- MACD
- ECVT -0.07
- KALV -0.21
- Stochastic Oscillator
- ECVT 2.54
- KALV 10.10
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.